InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-5.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Sabzevari Helen, 董事长兼首席执行官. Director active across 1 company, notably Precigen, INC.. Cumulatively, 18 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €37k. History available since 27 January 2023. The latest transaction was filed on 23 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sabzevari Helen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
20,833 股Common StockSEC:0000950103-26-012870:0
10,184 股@ US$7.20Common StockSEC:0000950103-26-012870:1
321,100 股Common StockSEC:0000950103-26-004489:0
1,079,137 股Common StockSEC:0000950103-25-006143:0
825,000 股0Common StockSEC:0000950103-25-001481:0
1,071,429 股Common StockSEC:0000950103-24-005095:0
141,587 股Common StockSEC:0000950103-23-012774:0
141,587 股Common StockSEC:0000950103-23-012318:0
141,587 股Common StockSEC:0000950103-23-011942:0
141,587 股Common StockSEC:0000950103-23-011610:0
283,173 股Common StockSEC:0000950103-23-004824:0
22,857 股@ US$1.75100.0% 占其流量Common StockSEC:0000950103-23-001415:0
标准退出：2023年4月27日 (T+90)
17,665 股Common StockSEC:0000950103-23-000200:0
340,909 股Common StockSEC:0000950103-22-008541:0
17,667 股Common StockSEC:0000950103-22-000271:0
9,765 股Common StockSEC:0000950103-22-000138:0
25,000 股Common StockSEC:0000950103-21-010821:0
97,276 股Common StockSEC:0000950103-21-007276:0
18 条申报中的 18 条
About Sabzevari Helen
Sabzevari Helen is President and CEO at Precigen, INC. on XNAS. She has 16 filings in total, and the most recent filings available cover the period from 2021-05-14 to 2026-03-20. Across this sample of 16 filings, the total buy amount is EUR 36716, the total sell amount is EUR 0, and the most frequent transaction nature is option exercise.
